[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medicus Pharma Ltd (MDCX)

Medicus Pharma Ltd (MDCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,029
  • Shares Outstanding, K 56,658
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,460 K
  • EBIT $ -38 M
  • EBITDA $ -38 M
  • 60-Month Beta -0.05
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 11.25
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.21
  • Most Recent Earnings $-0.31 on 05/14/26
  • Next Earnings Date 08/10/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.14
  • Number of Estimates 2
  • High Estimate $-0.12
  • Low Estimate $-0.15
  • Prior Year $-0.43
  • Growth Rate Est. (year over year) +67.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3117 +2.09%
on 07/27/26
0.4922 -35.35%
on 06/30/26
-0.1398 (-30.52%)
since 06/26/26
3-Month
0.2500 +27.28%
on 05/05/26
0.4922 -35.35%
on 06/30/26
+0.0212 (+7.14%)
since 04/27/26
52-Week
0.2500 +27.28%
on 05/05/26
3.0500 -89.57%
on 09/23/25
-2.6118 (-89.14%)
since 07/25/25

Most Recent Stories

More News
Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome

PHILADELPHIA, July 27, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

MDCX : 0.3182 (-14.00%)
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings

NEW YORK CITY, NY / ACCESS Newswire / July 25, 2026 / New to The Street, one of America's longest-running sponsored business television brands, today announced the broadcast of its latest episode, airing...

CAST : 1.8900 (-2.07%)
RHNO : 6.0000 (+14.72%)
PETV : 0.6236 (-13.39%)
VTIX : 2.18 (-17.42%)
LTRN : 2.79 (+1.45%)
MDCX : 0.3182 (-14.00%)
BSIN : 1.2000 (-6.25%)
DVLT : 0.3557 (-0.42%)
COCH : 0.6740 (+1.71%)
Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

MDCX : 0.3182 (-14.00%)
New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group

Honoring Economic Freedom and American Capitalism Through Television That Connects Markets, Entrepreneurs, and Investors

CAST : 1.8900 (-2.07%)
PETV : 0.6236 (-13.39%)
LTRN : 2.79 (+1.45%)
MDCX : 0.3182 (-14.00%)
YYGH : 1.2500 (+6.84%)
BSIN : 1.2000 (-6.25%)
DVLT : 0.3557 (-0.42%)
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026

PHILADELPHIA, June 22, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

MDCX : 0.3182 (-14.00%)
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA

Featured Interviews Include Aeries Technology (NASDAQ: AERT), Virtuix Holdings (NASDAQ: VTIX), and EmpowerLit; Sponsored Programming Supported by DataVault AI (NASDAQ: DVLT), IGC Pharma (NYSE American:...

IGC : 0.2630 (-0.38%)
VTIX : 2.18 (-17.42%)
AERT : 6.46 (-1.67%)
MDCX : 0.3182 (-14.00%)
NRXP : 3.63 (-3.20%)
DVLT : 0.3557 (-0.42%)
Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome

PHILADELPHIA, June 15, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

MDCX : 0.3182 (-14.00%)
New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA

Brent Lucas, CEO of Envoy Medical (NASDAQ:COCH), Discusses the Company's Breakthrough Fully Implanted Hearing Device Designed to Deliver 24-Hour Hearing

RDZN : 1.2500 (+5.04%)
IGC : 0.2630 (-0.38%)
MDCX : 0.3182 (-14.00%)
DVLT : 0.3557 (-0.42%)
COCH : 0.6740 (+1.71%)
Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program

PHILADELPHIA, June 11, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

MDCX : 0.3182 (-14.00%)
Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission

PHILADELPHIA, June 08, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

MDCX : 0.3182 (-14.00%)

Business Summary

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

See More

Key Turning Points

3rd Resistance Point 0.4282
2nd Resistance Point 0.4036
1st Resistance Point 0.3609
Last Price 0.3182
1st Support Level 0.2936
2nd Support Level 0.2690
3rd Support Level 0.2263

See More

52-Week High 3.0500
Fibonacci 61.8% 1.9804
Fibonacci 50% 1.6500
Fibonacci 38.2% 1.3196
Last Price 0.3182
52-Week Low 0.2500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.